|
|
|
40
|
23516
|
PHENYLEPHRINE MINIMS 10% EYE DR (CAM/STO)
|
PHENYLEPHRINE
|
PHENYLEPHRINE MINIMS
|
20X0.5ML
|
B
|
94.73
|
4.74
|
EYE DROP
|
0
|
AMP
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
5224
|
EENT MYDRIATICS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
23518
|
PHENYLEPHRINE MINIMS 10% EYE DR (CAM) (BQ)
|
PHENYLEPHRINE
|
PHENYLEPHRINE MINIMS
|
20X0.5ML
|
BQ
|
82.53
|
4.1264
|
AMPP
|
0
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5224
|
EENT MYDRIATICS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT MYDRIATICS
|
|
|
|
|
40
|
23539
|
PHENYLEPHRINE 10MG/ML INJ (SLS/AHI)
|
PHENYLEPHRINE
|
PHENYLEPHRINE
|
1ML AMP
|
B
|
22.07
|
22.07
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121204
|
ALPHA ADRENERGIC AGONIST
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
40
|
2353D
|
PHRINTEC 10MG/ML IV/IM INJ (UBI/RXP) PHENYLEP
|
PHENYLEPHRINE
|
PHRINTEC
|
1ML VIAL
|
B
|
10.60
|
10.60
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
121204
|
ALPHA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
2353F
|
PHENYLEPHRINE 10MG/ML INJ (OMG) (BQ)
|
PHENYLEPHRINE
|
PHENYLEPHRINE
|
10X1ML
|
BQ
|
66.33
|
6.6327
|
VIAL
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
121204
|
ALPHA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV/IM/SC
|
0
|
ALPHA ADRENERGIC AGONIST
|
|
|
|
|
40
|
23541
|
PHENYLEPHRINE MINIMS 2.5% EYE DR (CAM/STO)
|
PHENYLEPHRINE
|
PHENYLEPHRINE MINIMS
|
20X0.5ML
|
B
|
94.73
|
4.74
|
EYE DROP
|
0
|
AMP
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
5224
|
EENT MYDRIATICS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
23548
|
PHENYLEPHRINE MINIMS 2.5% EYE DR (CAM) (BQ)
|
PHENYLEPHRINE
|
PHENYLEPHRINE MINIMS
|
20X0.5ML
|
BQ
|
82.53
|
4.1264
|
AMPP
|
0
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5224
|
EENT MYDRIATICS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT MYDRIATICS
|
|
|
|
|
40
|
32936
|
PREPARATION H 0.25% SUPPOS (GSK/COL) PHENYLEP
|
PHENYLEPHRINE
|
PREPARATION H
|
12'S
|
A
|
14.08
|
1.17
|
SUPPOSITORY
|
12
|
SUPP
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
6
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
32936
|
PREPARATION H 0.25% SUPPOS (GSK) PH
|
PHENYLEPHRINE
|
PREPARATION H
|
12'S
|
A
|
14.79
|
1.2323
|
SUPP
|
12
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
6
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
40
|
3294S
|
PREPRATION H MULTI-SYMPTOM 0.25% | 1% CR (GSK/COL) PHENYLEPHRINE | PRAMOXINE
|
PHENYLEPHRINE|PRAMOXINE
|
PREPRATION H MULTI-SYMPTOM
|
26G
|
A
|
12.69
|
12.69
|
CREAM
|
1
|
TUBE
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
3294S
|
PREPRATION H MULTI-SYMPTOM 0.25%|1% CR (GSK) PHENYLEPHRINE|P
|
GLYCERINE|PHENYLEPHRINE|PRAMOXINE
|
PREPRATION H MULTI-SYMPTOM
|
26G
|
A
|
13.35
|
13.347
|
TUBE
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
41
|
4061F
|
OPTICOOL 0.05%|0.12% EYE DR (SHC) NAPHAZOLINE|PHENYLEPHRINE
|
NAPHAZOLINE|PHENYLEPHRINE
|
OPTICOOL
|
10ML
|
A
|
3.59
|
3.5882
|
BOTT
|
1
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT VASOCONSTRICTORS
|
|